Sleep disorders after COVID-19 in Czech population: Post-lockdown national online survey
Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
37811367
PubMed Central
PMC10551886
DOI
10.1016/j.sleepx.2023.100087
PII: S2590-1427(23)00027-7
Knihovny.cz E-zdroje
- Klíčová slova
- Dream-enactment behaviour, Long COVID, Nightmare, Parasomnia, Post-COVID syndrome, Prevalence, SARS-CoV-2,
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: This study aimed to determine the frequency, type, and correlates of a broad spectrum of sleep disorders in adults with COVID-19 up to 32 months after infection. METHODS: We conducted a national online survey (Jun 2021-Dec 2022), gathering information on COVID-19 diagnosis, acute disease course, and the subsequent development of sleep disorders from 1507 respondents (mean age 44.5 ± 13.1 years, 64.1% women). RESULTS: 81.3% (1223) reported at least one sleep difficulty that either worsened or first appeared with COVID-19. Females reported a higher number of symptoms (2.03 ± 1.44 versus 1.72 ± 1.43 in men, p < 0.0001). Most common were insomnia symptoms (59.4%), followed by night sweats (38.4%), hypersomnolence (33.3%), vivid dreams or nightmares (26.4%), restless leg syndrome (RLS) (22.8%), and sleep-related breathing disorders (11.1%). All symptoms were associated with a more severe acute disease. A mild decreasing trend in the persistence of sleep symptoms with a longer latency since infection was observed, with 66.7% reporting at least half of their symptoms present at 3-5 months after acute infection, compared to 64.9% at 6-8 months, and 62.4% at 9-11 months (p = 0.0427). However, among those after 12 or more months, over half of the symptoms persisted in 69.5%. The frequency of vivid dreams and nightmares increased in association with COVID-19 in 32.9% (p < 0.001). 9.4% (141) reported new-onset or increased parasomnic manifestations after the infection. CONCLUSIONS: Our research shows that sleep disturbances are a common and persistent manifestation of COVID-19 that affects a large proportion of the population and deserves careful monitoring.
Zobrazit více v PubMed
Di Carlo D.T., Montemurro N., Petrella G., Siciliano G., Ceravolo R., Perrini P. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature. J Neurol. 2021;268(5):1561–1569. doi: 10.1007/s00415-020-09978-y. PubMed DOI PMC
Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127. PubMed DOI PMC
Paterson R.W., Brown R.L., Benjamin L., et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104–3120. doi: 10.1093/brain/awaa240. PubMed DOI PMC
Ousseiran Z.H., Fares Y., Chamoun W.T. Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int J Neurosci. 2021;27:1–16. doi: 10.1080/00207454.2021.1973000. Published online September. PubMed DOI PMC
Carfì A., Bernabei R., Landi F. For the gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi: 10.1001/jama.2020.12603. PubMed DOI PMC
Liguori C., Pierantozzi M., Spanetta M., et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020;88:11–16. doi: 10.1016/j.bbi.2020.05.037. PubMed DOI PMC
Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8. PubMed DOI PMC
Alimoradi Z., Broström A., Tsang H.W.H., et al. Sleep problems during COVID-19 pandemic and its' association to psychological distress: a systematic review and meta-analysis. EClinicalMedicine. 2021;36 doi: 10.1016/j.eclinm.2021.100916. PubMed DOI PMC
Partinen M., Holzinger B., Morin C.M., et al. Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire. BMJ Open. 2021;11(12) doi: 10.1136/bmjopen-2021-050672. PubMed DOI PMC
Pinto J., van Zeller M., Amorim P., et al. Sleep quality in times of COVID-19 pandemic. Sleep Med. 2020;74:81–85. doi: 10.1016/j.sleep.2020.07.012. PubMed DOI PMC
Akbarialiabad H., Taghrir M.H., Abdollahi A., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163–1186. doi: 10.1007/s15010-021-01666-x. PubMed DOI PMC
World Health Organization . 2022. Post COVID-19 condition (long COVID). World health organization europe.https://www.who.int/europe/news-room/fact-sheets/item/post-COVID-19-condition Published December 7.
Postuma R.B., Arnulf I., Hogl B., et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov. Disord. Off. J. Mov. Disord. Soc. 2012;27(7):913–916. doi: 10.1002/mds.25037. PubMed DOI PMC
Fränkl E., Scarpelli S., Nadorff M.R., et al. How our dreams changed during the COVID-19 pandemic: effects and correlates of dream recall frequency - a multinational study on 19,355 adults. Nat Sci Sleep. 2021;13:1573–1591. doi: 10.2147/NSS.S324142. PubMed DOI PMC
Ellul M.A., Benjamin L., Singh B., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–783. doi: 10.1016/S1474-4422(20)30221-0. PubMed DOI PMC
Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019. PubMed DOI PMC
Jahrami H., BaHammam A.S., Bragazzi N.L., Saif Z., Faris M., Vitiello M.V. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med. 2021;17(2):299–313. doi: 10.5664/jcsm.8930. PubMed DOI PMC
Musse F.C.C., Castro L. de S., Sousa K.M.M., et al. Mental violence: the COVID-19 nightmare. Front Psychiatr. 2020;11 doi: 10.3389/fpsyt.2020.579289. PubMed DOI PMC
Deng J., Zhou F., Hou W., et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90–111. doi: 10.1111/nyas.14506. PubMed DOI PMC
Merikanto I., Dauvilliers Y., Chung F., et al. Sleep symptoms are essential features of long-COVID - comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II) J Sleep Res. 2023;32(1) doi: 10.1111/jsr.13754. PubMed DOI PMC
Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631. doi: 10.1038/s41591-021-01292-y. PubMed DOI PMC
Asadi-Pooya A.A., Akbari A., Emami A., et al. Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. 2021;46(6):428–436. doi: 10.30476/ijms.2021.92080.2326. PubMed DOI PMC
Alimoradi Z., Gozal D., Tsang H.W.H., et al. Gender-specific estimates of sleep problems during the COVID-19 pandemic: systematic review and meta-analysis. J Sleep Res. 2022;31(1) doi: 10.1111/jsr.13432. PubMed DOI PMC
Neculicioiu V., Colosi I., Costache C., Sevastre-Berghian A., Clichici S. Time to sleep? - a review of the impact of the COVID-19 pandemic on sleep and mental health. Int J Environ Res Publ Health. 2022;19:3497. doi: 10.3390/ijerph19063497. PubMed DOI PMC
Cénat J.M., Blais-Rochette C., Kokou-Kpolou C.K., et al. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: a systematic review and meta-analysis. Psychiatr Res. 2021;295 doi: 10.1016/j.psychres.2020.113599. PubMed DOI PMC
Liu Y., Partinen E., Chan N.Y., et al. Dream-enactment behaviours during the COVID-19 pandemic: an international COVID-19 sleep study. J Sleep Res. 2023;32(1) doi: 10.1111/jsr.13613. PubMed DOI PMC
Alzueta E., Perrin P.B., Yuksel D., et al. An international study of post-COVID sleep health. Sleep Health. 2022;8(6):684–690. doi: 10.1016/j.sleh.2022.06.011. PubMed DOI PMC
Alkodaymi M.S., Omrani O.A., Fawzy N.A., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2022;28(5):657–666. doi: 10.1016/j.cmi.2022.01.014. PubMed DOI PMC
Salfi F., Amicucci G., Corigliano D., et al. Two years after lockdown: longitudinal trajectories of sleep disturbances and mental health over the COVID-19 pandemic, and the effects of age, gender and chronotype. J Sleep Res. 2022;1 doi: 10.1111/jsr.13767. Published online November. PubMed DOI PMC
Lam M.H.B., Wing Y.K., Yu M.W.M., et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142–2147. doi: 10.1001/archinternmed.2009.384. PubMed DOI
Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathog. Basel Switz. 2022;11(2) doi: 10.3390/pathogens11020269. PubMed DOI PMC
Fang H., Tu S., Sheng J., Shao A. Depression in sleep disturbance: a review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019;23(4):2324–2332. doi: 10.1111/jcmm.14170. PubMed DOI PMC
COG-CZ - Česká Republika. Linie SARS-CoV-2 Detekované v Česku. COG-CZ - Česká Republika https://virus.img.cas.cz/lineages..
Nyberg T., Ferguson N.M., Nash S.G., et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet Lond Engl. 2022;399(10332):1303–1312. doi: 10.1016/S0140-6736(22)00462-7. PubMed DOI PMC